Breaking News

Cambrex Opens Large Scale API Mfg. Facility

Invests in supporting waste water treatment plant at its Karlskoga, Sweden site

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Cambrex Corporation, a manufacturer of small molecule innovator and generic active pharmaceutical ingredients (APIs), has completed the installation of new, large scale manufacturing capacity at its cGMP facility in Karlskoga, Sweden and has also undertaken a multi-year construction project to increase the site’s waste water processing capabilities. The expansion of the site’s manufacturing capabilities included the installation of various multi-purpose reactors, ranging from 4m3 to 12m3 in s...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters